INS and diabetes mellitus: Insulin therapy, which normalizes blood glucose without affecting the open KATP channel, prevented the changes in insulin- and glucagon-staining, β-cell ultrastructure and number of ins+/glu+ cells produced by 4 weeks of diabetes.